These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 11349053)

  • 1. Elevated cytokine and chemokine levels and prolonged pulmonary airflow resistance in a murine Mycoplasma pneumoniae pneumonia model: a microbiologic, histologic, immunologic, and respiratory plethysmographic profile.
    Hardy RD; Jafri HS; Olsen K; Wordemann M; Hatfield J; Rogers BB; Patel P; Duffy L; Cassell G; McCracken GH; Ramilo O
    Infect Immun; 2001 Jun; 69(6):3869-76. PubMed ID: 11349053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection.
    Ríos AM; Mejías A; Chávez-Bueno S; Fonseca-Aten M; Katz K; Hatfield J; Gómez AM; Jafri HS; McCracken GH; Ramilo O; Hardy RD
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2897-904. PubMed ID: 15273098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of LBM415 (NVP PDF-713), a novel peptide deformylase inhibitor, for treatment of experimental Mycoplasma pneumoniae pneumonia.
    Fonseca-Aten M; Salvatore CM; Mejías A; Ríos AM; Chávez-Bueno S; Katz K; Gómez AM; McCracken GH; Hardy RD
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4128-36. PubMed ID: 16189089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice.
    Jafri HS; Chavez-Bueno S; Mejias A; Gomez AM; Rios AM; Nassi SS; Yusuf M; Kapur P; Hardy RD; Hatfield J; Rogers BB; Krisher K; Ramilo O
    J Infect Dis; 2004 May; 189(10):1856-65. PubMed ID: 15122522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory tract infection with Mycoplasma pneumoniae in interleukin-12 knockout mice results in improved bacterial clearance and reduced pulmonary inflammation.
    Salvatore CM; Fonseca-Aten M; Katz-Gaynor K; Gomez AM; Mejias A; Somers C; Chavez-Bueno S; McCracken GH; Hardy RD
    Infect Immun; 2007 Jan; 75(1):236-42. PubMed ID: 17074851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycoplasma pneumoniae induces host-dependent pulmonary inflammation and airway obstruction in mice.
    Fonseca-Aten M; Ríos AM; Mejías A; Chávez-Bueno S; Katz K; Gómez AM; McCracken GH; Hardy RD
    Am J Respir Cell Mol Biol; 2005 Mar; 32(3):201-10. PubMed ID: 15626776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycoplasma pneumoniae induces chronic respiratory infection, airway hyperreactivity, and pulmonary inflammation: a murine model of infection-associated chronic reactive airway disease.
    Hardy RD; Jafri HS; Olsen K; Hatfield J; Iglehart J; Rogers BB; Patel P; Cassell G; McCracken GH; Ramilo O
    Infect Immun; 2002 Feb; 70(2):649-54. PubMed ID: 11796594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial and immunologic activities of clarithromycin in a murine model of Mycoplasma pneumoniae-induced pneumonia.
    Hardy RD; Rios AM; Chavez-Bueno S; Jafri HS; Hatfield J; Rogers BB; McCracken GH; Ramilo O
    Antimicrob Agents Chemother; 2003 May; 47(5):1614-20. PubMed ID: 12709330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal interleukin-12 therapy inhibits Mycoplasma pneumoniae clearance and sustains airway obstruction in murine pneumonia.
    Salvatore CM; Fonseca-Aten M; Katz-Gaynor K; Gomez AM; Hardy RD
    Infect Immun; 2008 Feb; 76(2):732-8. PubMed ID: 18039833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Airway inflammation and bronchial hyperresponsiveness after Mycoplasma pneumoniae infection in a murine model.
    Martin RJ; Chu HW; Honour JM; Harbeck RJ
    Am J Respir Cell Mol Biol; 2001 May; 24(5):577-82. PubMed ID: 11350827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tigecycline therapy significantly reduces the concentrations of inflammatory pulmonary cytokines and chemokines in a murine model of Mycoplasma pneumoniae pneumonia.
    Salvatore CM; Techasaensiri C; Tagliabue C; Katz K; Leos N; Gomez AM; McCracken GH; Hardy RD
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1546-51. PubMed ID: 19139287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Protective immune responses induced by intranasal immunization with Mycoplasma pneumoniae P1C-IL-2 fusion DNA vaccine in mice].
    Zhu C; Yu M; Gao S; Zeng Y; You X; Wu Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jun; 29(6):585-8. PubMed ID: 23746241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated respiratory Mycoplasma pneumoniae infections in mice: effect of host genetic background.
    Chu HW; Breed R; Rino JG; Harbeck RJ; Sills MR; Martin RJ
    Microbes Infect; 2006 Jun; 8(7):1764-72. PubMed ID: 16713727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycoplasma pneumoniae infection in a pediatric population: analysis of soluble immune markers as risk factors for asthma.
    Hassan J; Irwin F; Dooley S; Connell J
    Hum Immunol; 2008 Dec; 69(12):851-5. PubMed ID: 18835573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimentally induced Mycoplasma pneumoniae pneumonia in chimpanzees.
    Barile MF; Grabowski MW; Kapatais-Zoumbos K; Brown B; Hu PC; Chandler DK
    Microb Pathog; 1993 Oct; 15(4):243-53. PubMed ID: 8309353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses in Mycoplasma pneumoniae infection of infant mouse and of man.
    Kanamori M; Katsura T; Ishiyama N; Ogata S; Kitamoto O
    Isr J Med Sci; 1987 Jun; 23(6):568-73. PubMed ID: 3117730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A latex-induced allergic airway inflammation model in mice.
    Farzaneh P; Hassan ZM; Pourpak Z; Hoseini AZ; Hogan SP
    Basic Clin Pharmacol Toxicol; 2006 Dec; 99(6):405-11. PubMed ID: 17169120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma.
    Deng YM; Xie QM; Tang HF; Sun JG; Deng JF; Chen JQ; Yang SY
    Eur J Pharmacol; 2006 Oct; 547(1-3):125-35. PubMed ID: 16956605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine secretion in children with acute Mycoplasma pneumoniae infection and wheeze.
    Esposito S; Droghetti R; Bosis S; Claut L; Marchisio P; Principi N
    Pediatr Pulmonol; 2002 Aug; 34(2):122-7. PubMed ID: 12112778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent airway hyper-responsiveness and inflammation in Toxocara canis-infected BALB/c mice.
    Pinelli E; Withagen C; Fonville M; Verlaan A; Dormans J; van Loveren H; Nicoll G; Maizels RM; van der Giessen J
    Clin Exp Allergy; 2005 Jun; 35(6):826-32. PubMed ID: 15969676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.